Latest Close
$4.35
News
ABUS
Arbutus Biopharma Corporation News
This news view pulls recent coverage and headlines tied to ABUS.
1y Change
$1.13 (+35.09%)
Market Cap
$859,289,024.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Arbutus Biopharma Swings to Profit in Q1, Revenue Rises; Shares Up Pre-Bell
MT Newswires • May 13, 2026
Read articleArbutus: Q1 Earnings Snapshot
Associated Press • May 13, 2026
Read articleArbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire • May 13, 2026
Read articleThe Zacks Analyst Blog Highlights Moderna, Merck and Vertex Pharmaceuticals
Zacks • May 4, 2026
Read articleModerna’s Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway.
Barrons.com • May 1, 2026
Read articleModerna Reports Q1 Loss, Stock Jumps on Strong International Sales
Zacks • May 1, 2026
Read article